Jefferson Capital (JCAP) awards stock options to US business chief

Rhea-AI Filing Summary

Zellmann Mark Joseph reported acquisition or exercise transactions in this Form 4 filing.

Jefferson Capital executive Mark Joseph Zellmann, President US Business Lines, received two grants of stock options, each covering 12,500 shares of common stock. The Form 4 classifies these as compensation-related grants or awards rather than open-market purchases.

The reported transaction prices for the option grants are $20.13 and $34.13 per share, with both option series expiring on March 17, 2036. According to the footnote, the options vest in equal 1/5 installments each year, subject to Mr. Zellmann’s continued service through each vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zellmann Mark Joseph

(Last) (First) (Middle)

C/O JEFFERSON CAPITAL, INC.

600 SOUTH HIGHWAY 169, SUITE 1575

(Street)

MINNEAPOLIS MINNESOTA 55426

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jefferson Capital, Inc. / DE [ JCAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President US Business Lines

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	(1)	03/18/2026		A		12,500		(1)	03/17/2036	Common Stock	12,500	$20.13	12,500	D
Stock option (right to buy)	(1)	03/18/2026		A		12,500		(1)	03/17/2036	Common Stock	12,500	$34.13	12,500	D

Explanation of Responses:

1. The stock options vest as to 1/5th of the shares annually, subject to continued service through the vest date.

	/s/ Matthew J. Pfohl, Attorney-in-Fact for Mark Zellmann	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Jefferson Capital (JCAP) report for Mark Joseph Zellmann?

Jefferson Capital reported that executive Mark Joseph Zellmann received two grants of stock options, each for 12,500 shares of common stock. These are classified as compensation-related awards, not open-market purchases or sales, and increase his derivative-based exposure to Jefferson Capital shares.

What are the exercise terms and prices of the new Jefferson Capital (JCAP) stock options?

The Form 4 shows two stock option grants tied to Jefferson Capital common stock, each covering 12,500 shares. The reported transaction prices are $20.13 and $34.13 per share, with both option series scheduled to expire on March 17, 2036, if not exercised earlier.

How do the Jefferson Capital (JCAP) options granted to Mark Zellmann vest over time?

According to the filing footnote, the stock options granted to Mark Joseph Zellmann vest in five equal annual installments. One-fifth of the options vest each year, and vesting is conditioned on his continued service with Jefferson Capital through each applicable vesting date.

Are Mark Zellmann’s Jefferson Capital (JCAP) option grants open-market purchases or sales?

No, the Form 4 characterizes both Jefferson Capital transactions for Mark Joseph Zellmann with transaction code A, indicating grants or awards. These are compensation-related stock option grants, not open-market purchases or sales, and therefore do not represent discretionary trading in Jefferson Capital shares.

When do the newly granted Jefferson Capital (JCAP) stock options to Mark Zellmann expire?

Both series of stock options reported for Mark Joseph Zellmann share the same expiration date of March 17, 2036. This long-dated expiry gives him an extended window to potentially exercise the options, subject to the annual vesting and continued-service conditions described in the filing.